The metabolic rate during the time course of salicylate antipyresis in the rabbit

The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 1983-12, Vol.96 (3), p.193-200
Hauptverfasser: Gagało, Iwona T., Hać, Ewa E., Korolkiewicz, Konstanty Z.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 200
container_issue 3
container_start_page 193
container_title European journal of pharmacology
container_volume 96
creator Gagało, Iwona T.
Hać, Ewa E.
Korolkiewicz, Konstanty Z.
description The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg) was accompanied by increases in O 2 consumption and CO 2 production as well as decreases in convective heat loss. Pretreatment with 200 mg/kg of sodium salicylate (an hour's i.v. infusion) or with the same dose of acetylsalicylic acid (per os) significantly reduced pyrogen fever but the magnitude of O 2 consumption and CO 2 production remained at least at the febrile level. In the case of sodium salicylate, the level was even exceeded. At the same time both salicylates activated heat dissipation as manifested by decreases in vasomotor tone and tachypnea. Thus, it is apparent that the antipyretic effect of salicylates may develop without the inhibition of heat production. Heat loss processes initiated by these drugs are responsible for the antipyresis.
doi_str_mv 10.1016/0014-2999(83)90308-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80907730</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014299983903084</els_id><sourcerecordid>80907730</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-b12b12a862e90be9a1f4c1c6bf54064dd30f197395ffcb47510d8ca370e6c15c3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotVb_gcKeRA-rk012s7kIUvyCggj1HLLZiUb2oyZZof_erS09CgNzeJ-ZYR5CzincUKDFLQDlaSalvCrZtQQGZcoPyJSWQqYgaHZIpnvkmJyE8AUAuczyCZkUPCukyKfkbfmJSYtRV33jTOJ1xKQevOs-kjgm0bWYmH7wAZPeJkGP0LrZQLqLbrX2GFxIXPcHe11VLp6SI6ubgGe7PiPvjw_L-XO6eH16md8vUsNyEdOKZmPpsshQQoVSU8sNNUVlcw4Fr2sGlkrBZG6tqbjIKdSl0UwAFobmhs3I5XbvyvffA4aoWhcMNo3usB-CKkGCEAxGkG9B4_sQPFq18q7Vfq0oqI1JtdGkNppUydSfScXHsYvd_qFqsd4P7dSN-d02x_HJH4deBeOwM1g7jyaqunf_H_gF7YKCqw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80907730</pqid></control><display><type>article</type><title>The metabolic rate during the time course of salicylate antipyresis in the rabbit</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gagało, Iwona T. ; Hać, Ewa E. ; Korolkiewicz, Konstanty Z.</creator><creatorcontrib>Gagało, Iwona T. ; Hać, Ewa E. ; Korolkiewicz, Konstanty Z.</creatorcontrib><description>The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg) was accompanied by increases in O 2 consumption and CO 2 production as well as decreases in convective heat loss. Pretreatment with 200 mg/kg of sodium salicylate (an hour's i.v. infusion) or with the same dose of acetylsalicylic acid (per os) significantly reduced pyrogen fever but the magnitude of O 2 consumption and CO 2 production remained at least at the febrile level. In the case of sodium salicylate, the level was even exceeded. At the same time both salicylates activated heat dissipation as manifested by decreases in vasomotor tone and tachypnea. Thus, it is apparent that the antipyretic effect of salicylates may develop without the inhibition of heat production. Heat loss processes initiated by these drugs are responsible for the antipyresis.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/0014-2999(83)90308-4</identifier><identifier>PMID: 6426975</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Body Temperature - drug effects ; Body Temperature Regulation - drug effects ; Carbon Dioxide - biosynthesis ; CO 2 production ; Escherichia coli Infections ; Lipopolysaccharides - administration &amp; dosage ; Male ; O 2 consumption ; Oxygen Consumption - drug effects ; Rabbits ; Respiration - drug effects ; Respiratory frequency ; Salicylate antipyresis ; Salicylates - blood ; Salicylates - pharmacology ; Skin temperature ; Skin Temperature - drug effects ; Time Factors</subject><ispartof>European journal of pharmacology, 1983-12, Vol.96 (3), p.193-200</ispartof><rights>1983</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-b12b12a862e90be9a1f4c1c6bf54064dd30f197395ffcb47510d8ca370e6c15c3</citedby><cites>FETCH-LOGICAL-c357t-b12b12a862e90be9a1f4c1c6bf54064dd30f197395ffcb47510d8ca370e6c15c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0014-2999(83)90308-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27911,27912,45982</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6426975$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gagało, Iwona T.</creatorcontrib><creatorcontrib>Hać, Ewa E.</creatorcontrib><creatorcontrib>Korolkiewicz, Konstanty Z.</creatorcontrib><title>The metabolic rate during the time course of salicylate antipyresis in the rabbit</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg) was accompanied by increases in O 2 consumption and CO 2 production as well as decreases in convective heat loss. Pretreatment with 200 mg/kg of sodium salicylate (an hour's i.v. infusion) or with the same dose of acetylsalicylic acid (per os) significantly reduced pyrogen fever but the magnitude of O 2 consumption and CO 2 production remained at least at the febrile level. In the case of sodium salicylate, the level was even exceeded. At the same time both salicylates activated heat dissipation as manifested by decreases in vasomotor tone and tachypnea. Thus, it is apparent that the antipyretic effect of salicylates may develop without the inhibition of heat production. Heat loss processes initiated by these drugs are responsible for the antipyresis.</description><subject>Animals</subject><subject>Body Temperature - drug effects</subject><subject>Body Temperature Regulation - drug effects</subject><subject>Carbon Dioxide - biosynthesis</subject><subject>CO 2 production</subject><subject>Escherichia coli Infections</subject><subject>Lipopolysaccharides - administration &amp; dosage</subject><subject>Male</subject><subject>O 2 consumption</subject><subject>Oxygen Consumption - drug effects</subject><subject>Rabbits</subject><subject>Respiration - drug effects</subject><subject>Respiratory frequency</subject><subject>Salicylate antipyresis</subject><subject>Salicylates - blood</subject><subject>Salicylates - pharmacology</subject><subject>Skin temperature</subject><subject>Skin Temperature - drug effects</subject><subject>Time Factors</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotVb_gcKeRA-rk012s7kIUvyCggj1HLLZiUb2oyZZof_erS09CgNzeJ-ZYR5CzincUKDFLQDlaSalvCrZtQQGZcoPyJSWQqYgaHZIpnvkmJyE8AUAuczyCZkUPCukyKfkbfmJSYtRV33jTOJ1xKQevOs-kjgm0bWYmH7wAZPeJkGP0LrZQLqLbrX2GFxIXPcHe11VLp6SI6ubgGe7PiPvjw_L-XO6eH16md8vUsNyEdOKZmPpsshQQoVSU8sNNUVlcw4Fr2sGlkrBZG6tqbjIKdSl0UwAFobmhs3I5XbvyvffA4aoWhcMNo3usB-CKkGCEAxGkG9B4_sQPFq18q7Vfq0oqI1JtdGkNppUydSfScXHsYvd_qFqsd4P7dSN-d02x_HJH4deBeOwM1g7jyaqunf_H_gF7YKCqw</recordid><startdate>19831223</startdate><enddate>19831223</enddate><creator>Gagało, Iwona T.</creator><creator>Hać, Ewa E.</creator><creator>Korolkiewicz, Konstanty Z.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19831223</creationdate><title>The metabolic rate during the time course of salicylate antipyresis in the rabbit</title><author>Gagało, Iwona T. ; Hać, Ewa E. ; Korolkiewicz, Konstanty Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-b12b12a862e90be9a1f4c1c6bf54064dd30f197395ffcb47510d8ca370e6c15c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Animals</topic><topic>Body Temperature - drug effects</topic><topic>Body Temperature Regulation - drug effects</topic><topic>Carbon Dioxide - biosynthesis</topic><topic>CO 2 production</topic><topic>Escherichia coli Infections</topic><topic>Lipopolysaccharides - administration &amp; dosage</topic><topic>Male</topic><topic>O 2 consumption</topic><topic>Oxygen Consumption - drug effects</topic><topic>Rabbits</topic><topic>Respiration - drug effects</topic><topic>Respiratory frequency</topic><topic>Salicylate antipyresis</topic><topic>Salicylates - blood</topic><topic>Salicylates - pharmacology</topic><topic>Skin temperature</topic><topic>Skin Temperature - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gagało, Iwona T.</creatorcontrib><creatorcontrib>Hać, Ewa E.</creatorcontrib><creatorcontrib>Korolkiewicz, Konstanty Z.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gagało, Iwona T.</au><au>Hać, Ewa E.</au><au>Korolkiewicz, Konstanty Z.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The metabolic rate during the time course of salicylate antipyresis in the rabbit</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1983-12-23</date><risdate>1983</risdate><volume>96</volume><issue>3</issue><spage>193</spage><epage>200</epage><pages>193-200</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg) was accompanied by increases in O 2 consumption and CO 2 production as well as decreases in convective heat loss. Pretreatment with 200 mg/kg of sodium salicylate (an hour's i.v. infusion) or with the same dose of acetylsalicylic acid (per os) significantly reduced pyrogen fever but the magnitude of O 2 consumption and CO 2 production remained at least at the febrile level. In the case of sodium salicylate, the level was even exceeded. At the same time both salicylates activated heat dissipation as manifested by decreases in vasomotor tone and tachypnea. Thus, it is apparent that the antipyretic effect of salicylates may develop without the inhibition of heat production. Heat loss processes initiated by these drugs are responsible for the antipyresis.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>6426975</pmid><doi>10.1016/0014-2999(83)90308-4</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 1983-12, Vol.96 (3), p.193-200
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_80907730
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Body Temperature - drug effects
Body Temperature Regulation - drug effects
Carbon Dioxide - biosynthesis
CO 2 production
Escherichia coli Infections
Lipopolysaccharides - administration & dosage
Male
O 2 consumption
Oxygen Consumption - drug effects
Rabbits
Respiration - drug effects
Respiratory frequency
Salicylate antipyresis
Salicylates - blood
Salicylates - pharmacology
Skin temperature
Skin Temperature - drug effects
Time Factors
title The metabolic rate during the time course of salicylate antipyresis in the rabbit
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T23%3A53%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20metabolic%20rate%20during%20the%20time%20course%20of%20salicylate%20antipyresis%20in%20the%20rabbit&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Gaga%C5%82o,%20Iwona%20T.&rft.date=1983-12-23&rft.volume=96&rft.issue=3&rft.spage=193&rft.epage=200&rft.pages=193-200&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/0014-2999(83)90308-4&rft_dat=%3Cproquest_cross%3E80907730%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80907730&rft_id=info:pmid/6426975&rft_els_id=0014299983903084&rfr_iscdi=true